Bill Sibold left Avanir to launch Genzyme's MS drugs! Yep, Bill served less than a yr previous to Avanir as a CEO:
Bill Sibold is responsible for Genzyme’s Multiple Sclerosis franchise as the company prepares to launch two products.
Senior Vice President and Chief Commercial Officer, Avanir Pharmaceuticals
President and Chief Executive Officer, Lycera Corporation
"The CEO of Lycera, one of Michigan’s high-profile biotech startups, has left the company after less than a year on the job. CEO Bill Sibold, the former Biogen Idec executive who was hired to lead the Plymouth, MI-based startup in January, has resigned to pursue other interests, Xconomy has confirmed."
“Bill is a senior and experienced biotech executive with an excellent track record at Biogen, but both he and the board felt that the fit was not optimal with a heavily science based company like Lycera,” said Jeff Leiden, Lycera’s chairman, in an e-mailed statement.